RAB22A and glioma: Downregulation of miR-204-5p in human gliomas is correlated with poor patient prognosis, and overexpression of miR-204-5p inhibits the proliferation, migration and invasiveness of glioma cells in vitro and in vivo by directly targeting RAB22A (a member of the RAS oncogene family) [67].